Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-08T08:00:11.105Z Has data issue: false hasContentIssue false

Tetra-probe, 24-hour pH monitoring for laryngopharyngeal reflux: a technique for simultaneous study of hypopharynx, oesophagus and stomach

Published online by Cambridge University Press:  22 May 2009

K Sato*
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
H Umeno
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
S Chitose
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
T Nakashima
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
*
Address for correspondence: Dr Kiminori Sato, Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. Fax: +81 942 37 1200 E-mail: [email protected]

Abstract

Objective:

This study aimed to introduce the technique of tetra-probe, 24-hour pH monitoring for laryngopharyngeal reflux disease.

Methods:

Tetra-probe, 24-hour pH monitoring was performed for 30 suspected cases of laryngopharyngeal reflux. The proximal probe was placed in the hypopharynx, just above the upper oesophageal sphincter, the second probe was placed in the middle oesophagus, the third probe was placed a few centimetres above the lower oesophageal sphincter, and the distal probe was placed in the stomach.

Results:

As the pH at the four sensor sites could be monitored simultaneously, gastric acid levels and gastroesophageal and laryngopharyngeal reflux could be examined. This pH monitoring technique enabled the pH relationship between the four sensor locations to be well documented, enabling gastric acid levels and patterns of reflux to be assessed. This procedure was also able to be used as a functional examination to evaluate anti-reflux medication efficacy.

Conclusions:

Tetra-probe, 24-hour pH monitoring is a reliable functional examination for laryngopharyngeal reflux.

Type
Short Communication
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery, 19–22 September 2004, New York, New York, USA.

References

1Koufman, JA. Laryngopharyngeal reflux 2002: a new paradigm of airway disease. ENT J 2002;81(suppl 2):117122Google ScholarPubMed
2Koufman, JA, Aviv, JE, Casiano, RR, Shaw, GY. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32–5CrossRefGoogle Scholar
3Postma, GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol 2000;109(suppl 184):1014CrossRefGoogle Scholar
4Postma, GN, Belafsky, PC, Aviv, JE, Koufman JA: Laryngopharyngeal reflux testing. ENT J 2002;81(suppl 2):1418Google ScholarPubMed
5Sato, K. Tetra-probe 24-hour monitoring for laryngopharyngeal reflux diseases. J Jpn Bronchoesophagol Soc 2004;55:915CrossRefGoogle Scholar
6Feussner, H, Petri, A, Walker, S, Bollschweiner, E, Siewert, JR. The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg 1991;78:942–6CrossRefGoogle ScholarPubMed
7Smit, CF, Tan, J, Devriese, PP, Mathus-Vliegen, LMH, Brandsen, M, Schouwenburg, PF. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998;108:299302CrossRefGoogle ScholarPubMed
8Bough, ID Jr, Sataloff, RT, Castell, DO, Hills, JR, Gideon, RM, Spiegel, JR. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice 1995;9:205–11CrossRefGoogle ScholarPubMed
9Sato, K, Nakashima, T. Laryngopharyngeal reflux diseases resistant to antacid therapy. J Jpn Bronchoesophagol Soc 2004;55:414–22CrossRefGoogle Scholar
10Sato, K. Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy. Eur Arch Otolaryngol 2006;263:1121–6CrossRefGoogle ScholarPubMed
11Peghini, PL, Katz, PO, Bracy, NA, Castell, DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998;93:763–7CrossRefGoogle ScholarPubMed
12Ishizaki, T, Horai, Y. Review article. Cytochrome P450 and the metabolism of proton pump inhibitors – emphasis on rabeprazole. Aliment Pharmacol Ther 1999;13(suppl 3):2736CrossRefGoogle Scholar
13Adachi, K, Katsube, T, Kawamura, A, Takashima, T, Yuki, M, Amano, K, Ishihara, S, Fukuda, R, Watanabe, M, Kinoshita, Y.YP2C19 genotype status and intragastric pH during dosing with lansoplazole or rabeprazole. Aliment Pharmacol Ther 2000;14:1259–66CrossRefGoogle ScholarPubMed
14Axford, SE, Sharp, N, Ross, PE, Pearson, JP, Dettmar, PW, Panetti, M et al. Cell biology of laryngeal epithelial defences in health and disease. Preliminary studies. Ann Otol Rhinol Laryngol 2001;110:1099–108CrossRefGoogle ScholarPubMed